BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 4189987)

  • 1. [Immunofluorescent appearance of antinuclear antibodies and LE cells in connective tissue diseases].
    Kolarzowska B
    Pol Tyg Lek; 1970 Jan; 25(1):9-12. PubMed ID: 4189987
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antinuclear antibodies in disseminated lupus erythematosus and other connective tissue diseases].
    Velasco M; Losada M; Losada A; Ramirez G
    Rev Med Chil; 1968 Aug; 96(8):517-21. PubMed ID: 4915546
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative studies of immunofluorescent staining. VI. Defined complement immunofluorescent staining for antinuclear antibodies in systemic lupus and other collagen diseases.
    Diaz Gill GA; Beutner EH; Eisenberg RB
    Int Arch Allergy Appl Immunol; 1973; 45(6):868-79. PubMed ID: 4586867
    [No Abstract]   [Full Text] [Related]  

  • 4. The serology of connective tissue disorders.
    Holborow EJ
    Br J Hosp Med; 1978 Mar; 19(3):250, 252, 257-8. PubMed ID: 343858
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antinuclear antibodies in systemic lupus erythematosus before and after treatment and in chronic progressive polyarthritis. Some observations on the antiperinuclear factor].
    Marmont A; Damasio E
    J Belge Rhumatol Med Phys; 1967; 22(4):236-66. PubMed ID: 4185874
    [No Abstract]   [Full Text] [Related]  

  • 6. [Detection of antinuclear antibodies using chicken erythrocytes in lupus erythematosus, scleroderma, rheumatoid arthritis and juvenile chronic arthritis].
    Lucić N; Bosković B
    Med Arh; 1985; 39(2-3):65-8. PubMed ID: 3917218
    [No Abstract]   [Full Text] [Related]  

  • 7. [D-penicillamine induced lupus during the treatment of rheumatoid arthritis. Report of 2 cases and systematic immunologic study during the treatment].
    Crouzet J; Camus JP; Leca AP; Guillien P; Lièvre JA
    Ann Med Interne (Paris); 1974 Jan; 125(1):71-9. PubMed ID: 4136184
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum antinuclear antibodies (in patients with visceral erythematodes, rheumatoid arthritis, progressive systemic sclerosis and discoid erythematodes)].
    Horvat Z
    Acta Med Iugosl; 1970; 24(3):229-40. PubMed ID: 4928076
    [No Abstract]   [Full Text] [Related]  

  • 9. [Our experience in the study of nuclear and antinuclear constituant antibodies in rheumatology].
    Kahn MF; Dryll A; de Seze S
    J Belge Rhumatol Med Phys; 1967; 22(4):217-30. PubMed ID: 4185873
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of results of studies of the LE phenomenon and immunofluorescent studies in 100 patients with visceral lupus erythematosus].
    Kardaszewicz E
    Pol Tyg Lek; 1971 Mar; 26(9):297-300. PubMed ID: 4101394
    [No Abstract]   [Full Text] [Related]  

  • 11. [Routine immunofluorescence studies for demonstration of antinuclear factors].
    Hiemann D
    Z Gesamte Inn Med; 1969 May; 24(10):150-1. PubMed ID: 4185287
    [No Abstract]   [Full Text] [Related]  

  • 12. [Analysis of antinuclear antibodies (including LE test)].
    Tsunematsu T; Nakagawa J; Kusudo K
    Nihon Rinsho; 1976; 34 suppl():2619-31. PubMed ID: 62859
    [No Abstract]   [Full Text] [Related]  

  • 13. [Determination of antinuclear antibodies, anti-DNA antibodies, C 3 complement factor and IgG in lupus erythematosus and rheumatoid arthritis].
    Lehmann C; Hurtado R; Valdivieso M; Godoy G; Sorensen R
    Rev Med Chil; 1972; 100(5):485-9. PubMed ID: 4114175
    [No Abstract]   [Full Text] [Related]  

  • 14. The immunofluorescent "band" test for lupus erythematosus. 3. Employing clinically normal skin.
    Burnham TK; Fine G
    Arch Dermatol; 1971 Jan; 103(1):24-32. PubMed ID: 4099590
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antinuclear factors in systemic lupus erythematosus].
    Cossermelli W; Gomide WS; Pastor EM; Belliboni N; de Almeida TV
    AMB Rev Assoc Med Bras; 1978 Dec; 24(12):421-3. PubMed ID: 85319
    [No Abstract]   [Full Text] [Related]  

  • 16. [Morphologic and immunomorphologic studies in rheumatoid arthritis and systemic lupus erythematosus].
    Wagner T
    Patol Pol; 1984; 35(1):45-64. PubMed ID: 6333663
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sharp's syndrome. Clinical, immunological and nosographic aspects].
    Scagliusi P; Muratore M; Martiradonna A; Berlingerio G; Carrozzo M
    Minerva Med; 1980 Dec; 71(50):3655-63. PubMed ID: 6161325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of antinuclear factors in rheumatic diseases].
    Ménard HA; Myhal D; Camerlain M; Lussier A
    Union Med Can; 1974 Apr; 103(4):722-6. PubMed ID: 4601283
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of anti-DNA antibodies in SLE and in other connective tissue diseases by the use of native DNA. I. Technic].
    Damasio E; Rossi F
    Reumatismo; 1968; 20(2):104-7. PubMed ID: 4917819
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative studies of the demonstration of antinuclear factors by immunofluorescence and antiglobulin consumption tests].
    Schmidt K; Mueller-Eckhardt C; Becker W
    Verh Dtsch Ges Rheumatol; 1969; 1():251-8. PubMed ID: 4934585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.